Inflammation-based prognostic scores, including the neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, platelet to lymphocyte ratio and C-reactive protein/albumin ratio, have been analyzed to evaluate their prognostic predictive value in breast cancer, but the results are controversial (12, 13). The gene discussed is ALB; the disease is breast cancer.